Viridans streptococcal (Streptococcus intermedius) mitral valve subacute bacterial endocarditis (SBE) in a patient with mitral valve prolapse after a dental procedure: The importance of antibiotic prophylaxis

Heart and Lung: Journal of Acute and Critical Care

Volumn 39, Issue 1, 2010, Pages 64-72

  Cunha, Burke A ^a   D'Elia, Alexis A ^a   Pawar, Neha ^a   Schoch, Paul ^a  

^a WINTHROP UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; GENTAMICIN;

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL STRAIN; BLOOD CULTURE; BRAIN EMBOLISM; CASE REPORT; CONGENITAL HEART DISEASE; DOWN SYNDROME; DRUG TOLERANCE; DRUG TREATMENT FAILURE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEART MURMUR; HUMAN; LABORATORY TEST; LEG PAIN; LEG THROMBOSIS; MINIMUM INHIBITORY CONCENTRATION; MITRAL VALVE PROLAPSE; MITRAL VALVE REGURGITATION; MITRAL VALVE REPLACEMENT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PRIORITY JOURNAL; STREPTOCOCCUS INTERMEDIUS; SUBACUTE ENDOCARDITIS; TONIC CLONIC SEIZURE; TOOTH EXTRACTION; TRANSTHORACIC ECHOCARDIOGRAPHY; UNCONSCIOUSNESS;

ADULT; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; CEFTRIAXONE; COMORBIDITY; DOWN SYNDROME; ENDOCARDITIS, BACTERIAL; FEMALE; HEART MURMURS; HUMANS; MITRAL VALVE; MITRAL VALVE PROLAPSE; PRACTICE GUIDELINES AS TOPIC; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS INTERMEDIUS; TOOTH EXTRACTION;

EID: 77950021633     PISSN: 01479563     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrtlng.2009.01.004     Document Type: Article

References (39)

1. Brusch J.L. Infective endocarditis management in the era of intravascular devices 2007, Informa Healthcare, New York.
2. Kay D. Infective endocarditis (2nd ed 1992, Raven Press, ). New York.
3. Fujitani S., Rowlinson M.C., George W.L. Penicillin G-resistant viridans group streptococcal endocarditis and interpretation of the American Heart Association's Guideline for the Treatment of Infective Endocarditis. Clin Infect Dis 2008, 46:1064-1066.
4. Horstkotte D., Follath F., Gutschik E., et al. Guidelines on Prevention, Diagnosis and Treatment of Infective Endocarditis Executive Summary; the Task Force on Infective Endocarditis of the European Society of Cardiology. Eur Heart J 2004, 25:267-276.
5. Prevention of bacterial endocarditis. Circulation 1972, 46:3-6. American Heart Association.
6. Kaplan E.L. Prevention of bacterial endocarditis. Circulation 1977, 56:139-143.
7. Simmons N.A., Cawson R.A., Clarke C.E., et al. The antibiotic prophylaxis of infective endocarditis. Report of a working party of the British Society for Antimicrobial Chemotherapy. Lancet 1982, 2:1323-1326.
8. Simmons N.A., Cawson R.A., Clarke C.E., et al. Prophylaxis of infective endocarditis. Lancet 1986, 1:1267.
9. Simmons N.A., Cawson R.A., Eykyn S.J., et al. Antibiotic prophylaxis of infective endocarditis. Lancet 1990, 335:88-89.
10. Simmons Na, Ball A.P., Cawson R.A., et al. Antibiotic prophylaxis and infective endocarditis. Lancet 1992, 339:1292-1293.
11. Imperiale T.F., Horwitz R.I. Does prophylaxis prevent postdental infective endocarditis? A controlled evaluation of protective efficacy. Am J Med 1990, 88:131-136.
12. Morris C.D., Rellwer M.D., Menashe V.D. Thirty year incidence of infective endocarditis after surgery for congenital heart defect. JAMA 1998, 279:599-603.
13. Roberts H.W., Than C., Nevins S. Clinical consideration for infective endocarditis antibiotic prophylaxis. Gen Dent 1998, 46:89-91.
14. Gould F.K., Elliott T.S., Foweraker J., et al. Guidelines for the prevention of endocarditis report of the Working Party of the British Society for Antimicrobial Chemotherapy. Antimicrob Chemother 2006, 57:1035-1042.
15. Littler W.A., McGowan D.A., Shanson D.C. Changes in recommendations about amoxicillin prophylaxis for prevention of endocarditis. British Society for Antimicrobial Chemotherapy Endocarditis Working Party. Lancet 1997, 350:1100.
16. Prevention of rheumatic fever and bacterial endocarditis through control of streptococcal infections. Circulation 1955, 11:317-320. American Heart Association.
17. Schulman S.T., Amren D.P., Bisno A.L., et al. A statement for health professionals by the Committee on Rheumatic Fever and Infective Endocarditis of the Council on Cardiovascular Disease in the Young. Circulation 1984, 70:1123-1127.
18. Dajani A.S., Taubert K.A., Wilson W., et al. Prevention of bacterial endocarditis. Recommendations by the American Heart Association. JAMA 1997, 277:1794-1801.
19. Leport C., Horstkotte D., Burckhardt D. Antibiotic prophylaxis for infective endocarditis from an international group of experts towards a European consensus. Group of Experts of the International Society for Chemotherapy. Eur Heart J 1995, 16:126-131.
20. Durack D.T. Prevention of infective endocarditis. N Engl J Med 1995, 332:38-44.
21. Dajani A.S., Bisno A.L., Chung K.J., et al. Prevention of bacterial endocarditis. Recommendations by the American Heart Association. JAMA 1990, 264:2919-2922.
22. Van der Meer J.T., Van Wijk W., Thompson J., et al. Efficacy of antibiotic prophylaxis for prevention of native-valve endocarditis. Lancet 1992, 339:135-139.
23. Wilson W., Taubert K.A., Gewitz M., et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2007, 116:1736-1754.
24. Duval X., Leport C. Prophylaxis of infective endocarditis: current tendencies, continuing controversies. Lancet Infect Dis 2008, 8:225-232.
25. Cunha B.A., Gill M.V., Lazar J. Acute infective endocarditis. Infect Dis Clin North Am 1996, 10:811-834.
26. Cunha B.A. Antibiotic essentials 2009, Sudbury, MA, Jones & Bartlett. 8th ed.
27. Cunha B.A., Ortega A. Antibiotic failure. Med Clin North Am 1995, 79:663-672.
28. Acar J.F., Sabath L.D. Bacterial persistence in vivo: resistance or tolerance to antibiotics. Scand J Infect Dis Suppl 1978, 14:86-91.
29. Sabath L.D. Mechanisms of resistance to beta-lactam antibiotics in strains of Staphylococcus aureus. Ann Intern Med 1982, 3:339-344.
30. Cunha B.A., Mikail N., Eisenstein L. Persistent methicillin-resistant Staphylococcus aureus (MRSA) bacteremia due to a linezolid "tolerant" strain. Heart Lung 2008, 37:398-400.
31. Knoll B., Tleyjeh I.M., Steckelberg J.M., et al. Infective endocarditis due to penicillin-resistant viridans group streptococci. Clin Infect Dis 2007, 44:1585-1592.
32. Yap R.L., Mermel L.A., Maglio J. Antimicrobial resistant of community-acquired bloodstream isolates of viridans group streptococci. Infection 2006, 34:339-341.
33. Shelburne S.A., Greenberg S.B., Aslam S., et al. Successful ceftriaxone therapy of endocarditis due to penicillin non-susceptible viridans streptococci. J Infect 2007, 54:99-101.
34. Hsu R.B., Lin F.Y. Effect of penicillin resistance on presentation and outcome of nonenterococcal streptococcal infective endocarditis. Cardiology 2006, 105:234-239.
35. Mrazova M., Docze A., Buckova E., et al. Prospective national survey of viridans streptococcal bacteremia risk factors, antibacterial susceptibility and outcome of 120 episodes. Scand J Infect Dis 2005, 37:637-641.
36. Klakayama A., Takao A. Beta-lactam resistance in Streptococcus mitis isolated from saliva of healthy subjects. J Infect Chemother 2003, 9:321-327.
37. Levy C.S., Kogulan P., Gill V.J., et al. Endocarditis caused by penicillin resistant viridans streptococci: 2 cases and controversies in therapy. Clin Infect Dis 2001, 33:577-579.
38. Eng R.H., Wolff M., Smith S.M. Failure of erythromycin in preventing bacterial endocarditis. Arch Intern Med 1982, 142:1958-1959.
39. Durack D.T., Kaplan E.L., Bisno A. Apparent failures of endocarditis prophylaxis. Analysis of 52 cases submitted to a national registry. JAMA 1983, 250:2318-2322.